GFI #229 provides recommendations on study design and criteria drug manufacturers should use when evaluating the effectiveness of animal drugs intended to reduce STEC.
via What's New: Animal & Veterinary http://ift.tt/1EI97s0
via What's New: Animal & Veterinary http://ift.tt/1EI97s0
No comments:
Post a Comment